First in-human reverse LOT-CRT defibrillator
- PMID: 40762927
- DOI: 10.1007/s10840-025-02111-x
First in-human reverse LOT-CRT defibrillator
Conflict of interest statement
Declarations. Conflict of interest: NC reports consultant activities for Medtronic. All other authors declare no competing interests. Data availability: The data supporting the findings of this study are available from the corresponding author upon reasonable request.
References
-
- Jastrzębski M, Moskal P, Huybrechts W, et al. Left bundle branch-optimized cardiac resynchronization therapy (LOT-CRT): results from an international LBBAP collaborative study group. Heart Rhythm. 2022;19:13–21. https://doi.org/10.1016/j.hrthm.2021.07.057 . - DOI
-
- Nguyên UC, Rijks JHJ, Plesinger F, et al. Ultra-high-frequency ECG in cardiac pacing and cardiac resynchronization therapy: from technical concept to clinical application. J Cardiovasc Dev Dis. 2024;11: 76. https://doi.org/10.3390/jcdd11030076 . - DOI - PMC
-
- Ponnusamy SS, Ganesan V, Vijayaraman P. Feasibility, safety, and short-term follow-up of defibrillator lead at left bundle branch area pacing location: a pilot study. Heart Rhythm. 2024;21:1900–6. https://doi.org/10.1016/j.hrthm.2024.07.020 . - DOI
-
- Lopez JA. Implantable cardioverter defibrillator lead placement in the middle cardiac vein after tricuspid valve surgery. Europace. 2012;14:853–8. https://doi.org/10.1093/europace/eus013 . - DOI
LinkOut - more resources
Full Text Sources
Research Materials